In bladder and prostate cancer cells, HYAL1 seems to be the major tumor-derived hyaluronidase [139,140] and inhibition of hyaluronidase activity has been shown to suppress LNCaP-AI prostate tumor growth in a xenograft mouse model [141]. Here, HYAL1 is linked to neoplasm.